A novel drop regimen reduces ocular hypertension risk after pars plana vitrectomy Aditi27 Jan 2023 8:00 PM ISTUK: According to a research article published in Ophthalmologica, researchers have pointed out that following pars plana vitrectomy (PPV), drop ...
Diabetes Patients with Glaucoma have heightened risk of developing Retinopathy Dr.Niharika Harsha B21 Dec 2022 8:00 PM ISTDanish Researchers found that when compared to non-diabetic controls, diabetic patients are at increased risk of developing Glaucoma or Ocular...
FDA approves Omidenepag isopropyl eye drops for reduction of elevated IOP Dr. Kamal Kant Kohli27 Sept 2022 7:30 PM ISTUSA: Glaucoma causes damage to the optic nerve resulting in visual field loss, and remains a leading cause of irreversible blindness worldwide. Since...
Ocular hypertension in glaucoma patients is related to higher central corneal thickness: Study Jacinthlyn Sylvia25 July 2022 8:00 PM ISTUSA: In a new study conducted by Kristi Y. Wu and her team it was shown that in glaucoma patients, greater intraocular pressure and ocular...
Sandoz launches generic equivalent of AbbVie eyedrop Combigan in US Ruchika Sharma17 April 2022 10:15 AM IST"Fixed combinations of medicines to treat ocular hypertension can offer patients enhanced convenience, improved adherence, reduced exposure to...
Mindfulness-based stress reduction a potential approach in IOP management: Study Dr. Shravani Dali9 March 2022 9:00 AM ISTMindfulness-based stress reduction (MBSR) may be a potential approach in IOP management, according to a recent study published in the American ...
Intravitreal injections of dexamethasone implant not associated with ocular hypertension: Study MD Editorial Team23 Oct 2021 9:00 AM ISTFrance: Secondary ocular hypertension (OHT) is one of the most concerning adverse events of sustained-release dexamethasone intravitreal implant....
SPARC reports positive results from Phase 3 trial of ocular hypertension treatment Ruchika Sharma16 May 2021 10:00 AM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently reported positive top-line results from its Phase 3 trial (CLR_16_33) for...
Alembic Pharma gets USFDA nod to Timolol Maleate Ophthalmic Gel Forming Solution Ruchika Sharma26 Oct 2020 12:00 PM ISTTimolol Maleate Ophthalmic Gel Forming Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or...
Bimatoprost implant improves long term results in glaucoma treatment Medha Baranwal11 July 2020 12:11 PM ISTUSA: The bimatoprost implant has the potential to improve adherence and reduce the treatment burden in glaucoma, according to a recent study...
